| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |